Tags SeeThruEquity

Tag: SeeThruEquity

SeeThruEquity Healthcare Investor Conference in S.F. to feature MEDITE Cancer Diagnostics

NEWS: MEDITE Cancer Diagnostics, Inc. (OTC:MDIT / OTCMKTS:MDIT), specializing in the development, manufacturing, and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions announces today that CEO, Michaela Ott and CFO, Robert McCullough will present at the SeeThruEquity First Annual Microcap Healthcare Investor Conferfence.